Skip to search.
 TSX Up 2.43% TSX Ventures Up 0.55%

Abbott Laboratories (ABT)

-NYSE
37.13 Up 0.79(2.17%) Feb 12, 4:01PM EST
|After Hours : 37.14 Up 0.01 (0.02%) Feb 12, 4:57PM EST
Prev Close:36.34
Open:36.70
Bid:37.13 x 700
Ask:37.14 x 4300
1y Target Est:44.07
Beta:1.50583
Earnings Date:Apr 20 - Apr 25 (Est.)
Day's Range:36.40 - 37.15
52wk Range:36.00 - 51.74
Volume:6,424,843
Avg Vol (3m):7,089,460
Market Cap:55.39B
P/E (ttm):12.69
EPS (ttm):2.93
Div & Yield:1.04 (2.79%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ABTUp 2.17%55.39B

Key Statistics

Forward P/E (1 yr):15.41
P/S (ttm):2.66
Ex-Dividend Date:13-Jan-16

Analysts

Annual EPS Est (Dec-16) :2.16
Quarterly EPS Est (Mar-16) :0.39
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.81

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; int... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback